Rapid reviews with health-technology assessments in reimbursement systems – an examination of Ireland as a case study
IntroductionAs the pace of health-technology innovations increases, greater pressure is placed on health-technology assessment (HTA) agencies to review and make recommendations promptly. One response to this pressure is the use of rapid reviews (RRs). Since 2009 all new drugs in Ireland are first su...
Main Authors: | Aileen Murphy, Sandra Redmond |
---|---|
Format: | Article |
Language: | English |
Published: |
AboutScience Srl
2016-12-01
|
Series: | Global & Regional Health Technology Assessment |
Online Access: | http://www.grhta.com/Attach/52A735BD-70B1-4DC6-9203-912BADC09E31/3CD9C3AE-F655-42F0-94DF-72543D7A429D |
Similar Items
-
Health technology assessment and reimbursement of pharmaceuticals in Italy
by: F. V. Gorkavenko, et al.
Published: (2019-07-01) -
Health technology assessment and reimbursement policy for oncology orphan drugs in Central and Eastern Europe
by: Krzysztof Piotr Malinowski, et al.
Published: (2020-10-01) -
Role of centralized review processes for making reimbursement decisions on new health technologies in Europe
by: Stafinski T, et al.
Published: (2011-08-01) -
Exploring the advancing function of health technology assessments
by: Aileen Murphy
Published: (2016-10-01) -
Description of the use of multicriteria to support pricing and reimbursement decisions by European health technology assessment bodies
by: David Elvira, et al.
Published: (2021-08-01)